Dyne Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 29/07/2026 | Mar 2026Filed 29/07/2026 | Sep 2025Filed 05/11/2025 | Jun 2025Filed 29/07/2026 | Mar 2025Filed 29/07/2026 | Sep 2024Filed 05/11/2025 | Jun 2024Filed 05/11/2025 | Mar 2024Filed 05/11/2025 |
|---|---|---|---|---|---|---|---|---|
| −$179 | −$121 | −$108 | −$111 | −$115 | −$97 | −$65 | −$66 | |
| −$1.08 | −$0.73 | −$0.76 | −$0.97 | −$1.05 | −$0.96 | −$0.70 | −$0.81 |
Trend